PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35181615-8	2022	CONCLUSION: By targeting the Sirt1, EZH2 and CXCR4 pathways using relatively non-toxic adjuvant therapeutic agents such as metformin, melatonin, curcumin, sulforaphane, vitamin D3 and plerixafor, we should be able to target the biology of DLBCL.	Cholecalciferol	169-179	sirtuin 1	Homo sapiens	29-34	
34101754-0	2021	Vitamin D3 attenuates doxorubicin-induced senescence of human aortic endothelial cells by upregulation of IL-10 via the pAMPKalpha/Sirt1/Foxo3a signaling pathway.	Cholecalciferol	0-10	sirtuin 1	Homo sapiens	131-136	
34101754-4	2021	We further show the protective effects of vitamin D3 are mediated by the upregulation of IL-10 and FOXO3a expression through fine modulation of pAMPKalpha/SIRT1/FOXO3a complex activity.	Cholecalciferol	42-52	sirtuin 1	Homo sapiens	155-160	
34710370-0	2021	Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1.	Cholecalciferol	0-15	sirtuin 1	Homo sapiens	126-135	
35204824-0	2022	Vitamin D3 Stimulates Proliferation Capacity, Expression of Pluripotency Markers, and Osteogenesis of Human Bone Marrow Mesenchymal Stromal/Stem Cells, Partly through SIRT1 Signaling.	Cholecalciferol	0-10	sirtuin 1	Homo sapiens	167-172